Specifically mutated genes, mainly affected in ETP-ALL include members of the (PRC2) or genes reflecting the stem cell and myeloid character of ETP-ALL like FLT3, DNMT3A or KRAS. This mutation pattern of ETP-ALL opens up potential options for targeted therapies[21,22]. Here, DNMT3A is linked to acute lymphoblastic leukemia.